High-throughput PBTK models for in vitro to in vivo extrapolation

M Breen, CL Ring, A Kreutz, MR Goldsmith… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Toxicity data are unavailable for many thousands of chemicals in commerce
and the environment. Therefore, risk assessors need to rapidly screen these chemicals for …

IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

X Chang, YM Tan, DG Allen, S Bell, PC Brown… - Toxics, 2022 - mdpi.com
During the past few decades, the science of toxicology has been undergoing a
transformation from observational to predictive science. New approach methodologies …

[HTML][HTML] Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making

A Paini, JA Leonard, E Joossens, JGM Bessems… - Computational …, 2019 - Elsevier
The fields of toxicology and chemical risk assessment seek to reduce, and eventually
replace, the use of animals for the prediction of toxicity in humans. In this context …

Challenges associated with applying physiologically based pharmacokinetic modeling for public health decision-making

YM Tan, RR Worley, JA Leonard… - Toxicological …, 2018 - academic.oup.com
The development and application of physiologically based pharmacokinetic (PBPK) models
in chemical toxicology have grown steadily since their emergence in the 1980s. However …

A systematic review of published physiologically-based kinetic models and an assessment of their chemical space coverage

CV Thompson, JW Firman… - Alternatives to …, 2021 - journals.sagepub.com
Across multiple sectors, including food, cosmetics and pharmaceutical industries, there is a
need to predict the potential effects of xenobiotics. These effects are determined by the …

Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology

DE Watson, R Hunziker… - Experimental biology and …, 2017 - journals.sagepub.com
Microphysiological systems (MPS), which include engineered organoids (EOs), single
organ/tissue chips (TCs), and multiple organs interconnected to create miniature in vitro …

In silico resources to assist in the development and evaluation of physiologically-based kinetic models

JC Madden, G Pawar, MTD Cronin, S Webb… - Computational …, 2019 - Elsevier
Since their inception in pharmaceutical applications, physiologically-based kinetic (PBK)
models are increasingly being used across a range of sectors, such as safety assessment of …

[HTML][HTML] Development and intercomparison of single and multicompartment physiologically-based toxicokinetic models: Implications for model selection and tiered …

JM Armitage, L Hughes, A Sangion, JA Arnot - Environment international, 2021 - Elsevier
This study describes the development and intercomparison of generic physiologically-based
toxicokinetic (PBTK) models for humans comprised of internally consistent one-compartment …

Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications

A Paini, JA Leonard, T Kliment, YM Tan… - Regulatory Toxicology …, 2017 - Elsevier
Physiologically based kinetic (PBK) models are used widely throughout a number of working
sectors, including academia and industry, to provide insight into the dosimetry related to …

Integration of data across toxicity endpoints for improved safety assessment of chemicals: the example of carcinogenicity assessment

F Madia, G Pillo, A Worth, R Corvi, P Prieto - Archives of Toxicology, 2021 - Springer
In view of the need to enhance the assessment of consumer products called for in the EU
Chemicals Strategy for Sustainability, we developed a methodology for evaluating hazard by …